A novel candidate gene to rescue misprocessing of ΔF508 CFTR present in most patients with cystic fibrosis

被引:0
|
作者
Okiyoneda, T
Jono, H
Wada, I
Shuto, T
Yoshitake, K
Shibata, Y
Nagayama, S
Riordan, JR
Isohama, Y
Miyata, T
Kai, H
机构
[1] Kumamoto Univ, Kumamoto 8620973, Japan
[2] Sapporo Med Coll, Sapporo, Hokkaido, Japan
[3] Mayo Clin Scottsdale, Johnson Med Res Ctr, Scottsdale, AZ 85251 USA
关键词
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
2175
引用
收藏
页码:419A / 419A
页数:1
相关论文
共 50 条
  • [41] Cystic fibrosis in Argentina: The frequency of the Delta F508 mutation
    Luna, MC
    Granados, PA
    Olek, K
    Pivetta, OH
    HUMAN GENETICS, 1996, 97 (03) : 314 - 314
  • [42] EFFECT OF ΔF508 AND G551D CYSTIC FIBROSIS MUTATIONS ON CFTR-PKA INTERACTION
    Simon, Marton Andras
    Csanady, Laszlo
    EUROPEAN BIOPHYSICS JOURNAL WITH BIOPHYSICS LETTERS, 2023, 52 (SUPPL 1): : S157 - S157
  • [43] Identification of molecular determinants that modulate trafficking of ΔF508 CFTR, the mutant ABC transporter associated with cystic fibrosis
    Igor Tsigelny
    Matthew Hotchko
    Jason X. -J. Yuan
    Steven H. Keller
    Cell Biochemistry and Biophysics, 2005, 42 : 41 - 53
  • [44] 4-Chlorobenzo[F]isoquinoline (CBIQ), a novel activator of CFTR and ΔF508 CFTR
    Murthy, M
    Pedemonte, N
    MacVinish, L
    Galietta, L
    Cuthbert, A
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2005, 516 (02) : 118 - 124
  • [45] Identification of molecular determinants that modulate trafficking of ΔF508 CFTR, the mutant ABC transporter associated with cystic fibrosis
    Tsigelny, I
    Hotchko, M
    Yuan, JXJ
    Keller, SH
    CELL BIOCHEMISTRY AND BIOPHYSICS, 2005, 42 (01) : 41 - 53
  • [46] Prevalence of ΔF508 mutation in the cystic fibrosis transmembrane conductance regulator gene among cystic fibrosis patients from a Brazilian referral center
    Bieger, Andreia Marisa
    de Lima Marson, Fernando Augusto
    Bertuzzo, Carmen Silvia
    JORNAL DE PEDIATRIA, 2012, 88 (06) : 531 - 534
  • [47] Detection of the ΔF508 (F508del) mutation of the cystic fibrosis gene by surface plasmon resonance and biosensor technology
    Feriotto, G
    Lucci, M
    Bianchi, N
    Mischiati, C
    Gambari, R
    HUMAN MUTATION, 1999, 13 (05) : 390 - 400
  • [48] Lack of effect of delta F508 mutation on aerobic capacity in patients with cystic fibrosis
    Kaplan, TA
    MocciaLoos, G
    Rabin, M
    McKey, RM
    CLINICAL JOURNAL OF SPORT MEDICINE, 1996, 6 (04): : 226 - 231
  • [49] Analysis of the localization of STE6/CFTR chimeras in a Saccharomyces cerevisiae model for the cystic fibrosis defect CFTR Delta F508
    Paddon, C
    Loayza, D
    Vangelista, L
    Solari, R
    Michaelis, S
    MOLECULAR MICROBIOLOGY, 1996, 19 (05) : 1007 - 1017
  • [50] Evaluation of MRP1-5 gene expression in cystic fibrosis patients homozygous for the ΔF508 mutation
    Hurbain, I
    Sermet-Gaudelus, I
    Vallée, B
    Feuillet, MN
    Lenoir, G
    Bernaudin, JF
    Edelman, A
    Fajac, A
    PEDIATRIC RESEARCH, 2003, 54 (05) : 627 - 634